Randomized trial explores cognitive and functional improvements in narcolepsy after high dosages of low-sodium oxybate, suggesting potential benefits for patients.
To explore the impact of low-sodium oxybate (LXB; Xywav®) dosages >9 g/night on cognitive complaints, functional impairments, work productivity, and symptom severity in participants with narcolepsy who may benefit from higher LXB dosages, per investigator judgement.
No takes yet. Share an insight, caveat, or question.
Schneider et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: